Search research articles
Contact Us
Filters
Showing results (41-50 of 52) with videos related to
Page
of 6
Sort By:
International Journal of Paediatric Dentistry
|
April 20, 2001
An investigation of the oral status and reported oral care of children with heart and heart-lung transplants
M al-Sarheed, A Angeletou, P F Ashley, et al.
European Archives of Paediatric Dentistry : Official Journal of the European Academy of Paediatric Dentistry
|
March 4, 2009
Oral health of children with intractable epilepsy attending the UK National Centre for Young People with Epilepsy
T Percival, S E Aylett, F Pool, et al.
Heart (British Cardiac Society)
|
February 21, 2006
Duration, prevalence and intensity of bacteraemia after dental extractions in children
G J Roberts, E C Jaffray, D A Spratt, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1996
The effects of food and divided dosing on the bioavailability of oral vinorelbine
E K Rowinsky, V S Lucas, A L Hsieh, et al.
Community Dental Health
|
March 1, 1994
Patterns of breast and bottle feeding and their association with dental caries in 1- to 4-year-old South African children. 2. A case control study of children with nursing caries
G J Roberts, P E Cleaton-Jones, L P Fatti, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1993
Phase I clinical and pharmacology study of 502U83 given as a 24-h continuous intravenous infusion
R L Schilsky, M J Ratain, L Janisch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 29, 1998
Phase I clinical and pharmacologic study of eniluracil plus fluorouracil in patients with advanced cancer
R L Schilsky, J Hohneker, M J Ratain, et al.
Cancer Research
|
September 1, 1983
Phase I study of pharmacological and immunological effects of human lymphoblastoid interferon given to patients with cancer
J Laszlo, A T Huang, W D Brenckman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1994
Pharmacokinetic, bioavailability, and feasibility study of oral vinorelbine in patients with solid tumors
E K Rowinsky, D A Noe, D L Trump, et al.
Cancer Research
|
August 15, 1988
Phase I and clinical pharmacology trial of crisnatol (BWA770U mesylate) using a monthly single-dose schedule
G S Harman, J B Craig, J G Kuhn, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 52) with videos related to
Sort By:
Page
of 6
International Journal of Paediatric Dentistry
|
April 20, 2001
An investigation of the oral status and reported oral care of children with heart and heart-lung transplants
M al-Sarheed, A Angeletou, P F Ashley, et al.
European Archives of Paediatric Dentistry : Official Journal of the European Academy of Paediatric Dentistry
|
March 4, 2009
Oral health of children with intractable epilepsy attending the UK National Centre for Young People with Epilepsy
T Percival, S E Aylett, F Pool, et al.
Heart (British Cardiac Society)
|
February 21, 2006
Duration, prevalence and intensity of bacteraemia after dental extractions in children
G J Roberts, E C Jaffray, D A Spratt, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1996
The effects of food and divided dosing on the bioavailability of oral vinorelbine
E K Rowinsky, V S Lucas, A L Hsieh, et al.
Community Dental Health
|
March 1, 1994
Patterns of breast and bottle feeding and their association with dental caries in 1- to 4-year-old South African children. 2. A case control study of children with nursing caries
G J Roberts, P E Cleaton-Jones, L P Fatti, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1993
Phase I clinical and pharmacology study of 502U83 given as a 24-h continuous intravenous infusion
R L Schilsky, M J Ratain, L Janisch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 29, 1998
Phase I clinical and pharmacologic study of eniluracil plus fluorouracil in patients with advanced cancer
R L Schilsky, J Hohneker, M J Ratain, et al.
Cancer Research
|
September 1, 1983
Phase I study of pharmacological and immunological effects of human lymphoblastoid interferon given to patients with cancer
J Laszlo, A T Huang, W D Brenckman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1994
Pharmacokinetic, bioavailability, and feasibility study of oral vinorelbine in patients with solid tumors
E K Rowinsky, D A Noe, D L Trump, et al.
Cancer Research
|
August 15, 1988
Phase I and clinical pharmacology trial of crisnatol (BWA770U mesylate) using a monthly single-dose schedule
G S Harman, J B Craig, J G Kuhn, et al.
Page
of 6